Amneal Pharmaceuticals of New York, LLC recalls Exenatide Injection
- Published
- 30 Sept 2026
- Units affected
- 5,694 pens
- Agency
- FDA
- Country
- United States
The hazard
Defective Delivery System: Possibility of no medication in the prefilled pen.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
- Brand / company
- Amneal Pharmaceuticals of New York, LLC
- Codes / lots
- Lot #: AP250095A, Exp 2/28/2027
- Distribution
- USA Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 30 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.